Press Releases
CPhI China to Launch China Pharma Week
CPhI & P-MEC China 2017, hosted by UBM EMEA and China Chamber of Commerce ofMedicines & Health Products Importers& Exporters (CCCMHPIE), and co-organized by Shanghai UBM Sinoexpo, will be held on June 20-22, 2017 in Shanghai New International Expo...
Press Releases
Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC
Novartis announced that the US FDA accepted the Company's supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use of Zykadia®. Zykadia® (ceritinib) as a first-line treatment for patients with metastatic non-small...
Press Releases
Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products
Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary Obagi Medical Products, a long-time leader in professional skin care announced a collaboration with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, M.D.'s line of skin care products throughout the...
Press Releases
Recipharm completes strategic acquisition in India
Recipharm AB announces that it has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. Highlights Expands position in emerging markets significantly, taking sales in these markets to more than SEK 800...
Press Releases
SAVE FOOD China opens a new chapter in innovative food packaging together with packaging top brands
Shanghai World of Packaging - leading processing and packaging exhibition focusing on China and the Asia-Pacific region, is set for a grand opening in Shanghai New International Expo Centre from 7-10 November, 2017. The number of...
Press Releases
ERT Recognized for Improving and Accelerating Clinical Research
ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials announced it has been named a finalist for the Philadelphia Alliance for Capital and Technologies (PACT) Technology Company of the Year Award. ...
Press Releases
Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify Biomarkers for Angelman Syndrome
Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a privately held biotech company based in Madison, Wisconsin and Cambridge, Massachusetts. Â ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read